Medifast, Inc. (NYSE:MED) Q2 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Medifast Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Medifast Inc (MED)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 813,310 | $11,427,006 | -9% | 0.02% |
| 2. | D E Shaw D. E. Shaw | 321,229 | $4,513,267 | -4% | 0% |
| 3. | 301,700 | $4,238,885 | 0.01% | ||
| 4. | AQR Capital Management Cliff Asness | 220,131 | $3,092,841 | +11% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 212,900 | $2,991,245 | -3% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.13 | 381 | $5,002.53 | 149,698 | 2025-06-13 | Filing | |
| $68.89 | 50 | $3,471.16 | 6,253 | 2023-11-07 | Filing | |
| $68.89 | 50 | $3,428.24 | 8,375 | 2023-11-07 | Filing | |
| $68.89 | 53 | $3,626.78 | 10,538 | 2023-11-07 | Filing | |
| $68.89 | 58 | $4,019.87 | 5,784 | 2023-11-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $39.46 | 2,753 | $108,633.38 | 7,785 | 2024-03-08 | Filing | |
| $39.41 | 1,300 | $51,233.00 | 10,538 | 2024-03-08 | Filing | |
| $73.87 | 5,613 | $414,632.31 | 2,152 | 2023-10-06 | Filing | |
| $90.47 | 13,330 | $1,205,965.10 | 1 | 2023-08-15 | Filing | |
| $89.79 | 9,832 | $882,815.28 | 13,331 | 2023-08-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 899,184 | $12,633,536 | 0% | |
| 2. | 816,046 | $11,465,446 | 0% | |
| 3. | 695,200 | $9,767,560 | 0% | |
| 4. | 457,786 | $6,431,902 | 0% | |
| 5. | 421,169 | $5,917,424 | 0% |
News See All
Medifast, Inc. (NYSE:MED) Q1 2025 Earnings Call Transcript
Operator: Greetings. And welcome to the Medifast First Quarter 2025 Earnings Conference Call. At this time, all participants are in listen-only mode.
Medifast, Inc. (NYSE:MED) Q4 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Medifast Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Medifast, Inc. (NYSE:MED) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Medifast Third Quarter 2024 Earnings Conference Call. At this time, all participants are on a listen-only mode.
Medifast (MED): A Bull Case Theory
We came across a bullish thesis on Medifast (MED) on Value Degen’s Substack by Unemployed Value Degen. In this article we will summarize the bulls’ thesis on MED. Medifast, Inc.
Medifast, Inc. (NYSE:MED) Q2 2024 Earnings Call Transcript
Operator: And welcome to the Medifast Second Quarter 2024 Earnings Conference Call. At this time, all participants are on a listen-only mode.
Medifast, Inc. (NYSE:MED) Q1 2024 Earnings Call Transcript
Medifast, Inc. misses on earnings expectations. Reported EPS is $0.66 EPS, expectations were $0.78.
Here’s Why Miller Income Strategy Sold Medifast (MED)
Miller Value Partners, an investment management company, released its “Income Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Medifast, Inc. (NYSE:MED) Q4 2023 Earnings Call Transcript
Medifast, Inc. misses on earnings expectations. Reported EPS is $0.55 EPS, expectations were $0.99.
Reasons for the Decline of Medifast (MED) in Q4
Miller Value Partners, an investment management company, released its “Income Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
